| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.3 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |